Sung Lee
Insider Reports History
- Location
- Brisbane, CA
- Signature
- /s/ John O. Faurescu, attorney-in-fact for Mr. Lee
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Sung Lee:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| CYTOKINETICS INC | EVP, Chief Financial Officer | Common Stock | 87,127 | $5,414,943 | $62.15 | 17 Mar 2026 | Direct |
| Vir Biotechnology, Inc. | EVP & Chief Financial Officer | Common Stock | 100,492 | $993,615 | $9.89 | 27 Mar 2024 | Direct |
| Vir Biotechnology, Inc. | EVP & Chief Financial Officer | Stock Option (Right to Buy) | 80,000 | $122,400 | $1.53 | 22 Feb 2024 | Direct |
| Tango Therapeutics, Inc. | Director | Common Stock | 10,000 | $88,595 | $8.86 | 02 Jan 2026 | Direct |
| Tango Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 60,000 | 02 Jan 2026 | Direct | ||
| CYTOKINETICS INC | EVP, Chief Financial Officer | Non-Qualified Stock Option (Right to Buy) | 29,480 | 15 Mar 2026 | Direct | ||
| CYTOKINETICS INC | EVP, Chief Financial Officer | Incentive Stock Option (Right to Buy) | 1,665 | 15 Mar 2026 | Direct |
Insider Reports Filed by Sung Lee
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CYTK | CYTOKINETICS INC | 17 Mar 2026 | 1 | -$306,710 | 4 | EVP, Chief Financial Officer | 18 Mar 2026, 17:46 |
| CYTK | CYTOKINETICS INC | 15 Mar 2026 | 3 | $0 | 4 | EVP, Chief Financial Officer | 17 Mar 2026, 16:05 |
| TNGX | Tango Therapeutics, Inc. | 02 Jan 2026 | 2 | $0 | 4 | Director | 06 Jan 2026, 16:10 |
| TNGX | Tango Therapeutics, Inc. | 02 Jan 2026 | 0 | $0 | 3 | Director | 06 Jan 2026, 16:05 |
| CYTK | CYTOKINETICS INC | 22 Dec 2025 | 3 | -$50,490 | 4 | EVP, Chief Financial Officer | 29 Dec 2025, 16:03 |
| CYTK | CYTOKINETICS INC | 03 Dec 2025 | 1 | -$101,431 | 4 | EVP, Chief Financial Officer | 05 Dec 2025, 16:25 |
| CYTK | CYTOKINETICS INC | 02 Jun 2025 | 1 | -$154,958 | 4 | EVP, Chief Financial Officer | 03 Jun 2025, 16:02 |
| CYTK | CYTOKINETICS INC | 14 Mar 2025 | 3 | $0 | 4 | EVP, Chief Financial Officer | 18 Mar 2025, 16:24 |
| CYTK | CYTOKINETICS INC | 03 Dec 2024 | 3 | -$79,119 | 4 | EVP, Chief Financial Officer | 05 Dec 2024, 16:30 |
| CYTK | CYTOKINETICS INC | 31 May 2024 | 2 | $0 | 4 | EVP, Chief Financial Officer | 03 Jun 2024, 17:07 |
| CYTK | CYTOKINETICS INC | 26 Apr 2024 | 0 | $0 | 3 | EVP, Chief Financial Officer | 30 Apr 2024, 17:30 |
| VIR | Vir Biotechnology, Inc. | 27 Mar 2024 | 1 | -$59,404 | 4 | EVP & Chief Financial Officer | 28 Mar 2024, 12:18 |
| VIR | Vir Biotechnology, Inc. | 22 Feb 2024 | 2 | $0 | 4 | EVP & Chief Financial Officer | 26 Feb 2024, 19:32 |
| VIR | Vir Biotechnology, Inc. | 27 Mar 2023 | 2 | $0 | 4 | Chief Financial Officer | 29 Mar 2023, 17:49 |
| VIR | Vir Biotechnology, Inc. | 27 Mar 2023 | 0 | $0 | 3 | Chief Financial Officer | 29 Mar 2023, 17:47 |